These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8639804)
1. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804 [TBL] [Abstract][Full Text] [Related]
2. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Yamashita T; Barber DL; Zhu Y; Wu N; D'Andrea AD Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6712-6. PubMed ID: 7517562 [TBL] [Abstract][Full Text] [Related]
3. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer. Pulsipher M; Kupfer GM; Naf D; Suliman A; Lee JS; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea AD Mol Med; 1998 Jul; 4(7):468-79. PubMed ID: 9713825 [TBL] [Abstract][Full Text] [Related]
4. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension. Joenje H; Youssoufian H; Kruyt FA; dos Santos CC; Wevrick R; Buchwald M Blood Cells Mol Dis; 1995; 21(3):182-91. PubMed ID: 8673470 [TBL] [Abstract][Full Text] [Related]
5. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674 [TBL] [Abstract][Full Text] [Related]
6. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups. Li Y; Youssoufian H J Clin Invest; 1997 Dec; 100(11):2873-80. PubMed ID: 9389754 [TBL] [Abstract][Full Text] [Related]
7. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells. Otsuki T; Wang J; Demuth I; Digweed M; Liu JM Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445 [TBL] [Abstract][Full Text] [Related]
8. Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele. Youssoufian H; Li Y; Martin ME; Buchwald M J Clin Invest; 1996 Feb; 97(4):957-62. PubMed ID: 8613549 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819 [TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965 [TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex. Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664 [TBL] [Abstract][Full Text] [Related]
12. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Kupfer GM; Yamashita T; Naf D; Suliman A; Asano S; D'Andrea AD Blood; 1997 Aug; 90(3):1047-54. PubMed ID: 9242535 [TBL] [Abstract][Full Text] [Related]
13. The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Futaki M; Yamashita T; Yagasaki H; Toda T; Yabe M; Kato S; Asano S; Nakahata T Blood; 2000 Feb; 95(4):1493-8. PubMed ID: 10666230 [TBL] [Abstract][Full Text] [Related]
14. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787 [TBL] [Abstract][Full Text] [Related]
15. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Lo Ten Foe JR; Rooimans MA; Bosnoyan-Collins L; Alon N; Wijker M; Parker L; Lightfoot J; Carreau M; Callen DF; Savoia A; Cheng NC; van Berkel CG; Strunk MH; Gille JJ; Pals G; Kruyt FA; Pronk JC; Arwert F; Buchwald M; Joenje H Nat Genet; 1996 Nov; 14(3):320-3. PubMed ID: 8896563 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526 [TBL] [Abstract][Full Text] [Related]
18. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Kupfer GM; D'Andrea AD Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210 [TBL] [Abstract][Full Text] [Related]
19. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Gavish H; dos Santos CC; Buchwald M Hum Mol Genet; 1993 Feb; 2(2):123-6. PubMed ID: 8499901 [TBL] [Abstract][Full Text] [Related]
20. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]